FDA Drug Application (086024) for CAPITAL AND CODEINE by VALEANT PHARMS LLC

Back to FDA Applications sponsored by VALEANT PHARMS LLC

Application Number086024
Product Number001
FormSUSPENSION;ORAL
Dosage120MG/5ML;12MG/5ML
Product Market Status Prescription
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameCAPITAL AND CODEINE
Active IngredientACETAMINOPHEN; CODEINE PHOSPHATE

Active IngredientCount
List of drugs with Active Ingredient ACETAMINOPHEN107
List of drugs with Active Ingredient CODEINE PHOSPHATE51


Back to FDA Applications sponsored by VALEANT PHARMS LLC